Feb 01, 2021 - Feb 05, 2021 / NTS GMT
James Howard-Tripp - StageZero Life Sciences Ltd. - Chairman & CEO
Welcome to StageZero Life Sciences, a new kind of cancer company. And thank you for taking the time to look at our presentation. I would ask you to look through the forward-looking statements, read them carefully and please pay careful attention to them.
So to begin, 2020 for us was an absolutely critical year. It was obviously the advent of the pandemic to do with COVID-19. And as we saw, it changed healthcare very considerably, particularly in the cancer space. We, like most other groups, that could pivoted.
And it has had a very positive impact from a revenue perspective. But much more importantly, it has enabled us to grow our company out of very markedly in preparation for the launch of ARISTOTLE. And ARISTOTLE is what we're all about.
So we've more than double our size now in terms of where we were. Telehealth, which we are very heavily bet on, that's the way that healthcare was going. That has grown out very markedly. We're working with a large number of groups, large
StageZero Life Sciences Ltd at LSX World Congress (Virtual) Transcript
Feb 01, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers